Trimazosin
Jump to navigation
Jump to search
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII |
|
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.047.924 |
Chemical and physical data | |
Formula | C20H29N5O6 |
Molar mass | 435.481 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Trimazosin is a sympatholytic alpha-1 blocker.[1][2]
References
- ^ van Kalken CK, van der Meulen J, Oe PL, Vriesendorp R, Donker AJ (1986). "Pharmacokinetics of trimazosin and its effects on blood pressure, renal function and proteinuria during short-term therapy of patients with impaired renal function and hypertension". Eur. J. Clin. Pharmacol. 31 (1): 63–8. doi:10.1007/BF00870988. PMID 3780829. S2CID 19123951.
- ^ U.S. patent 3,669,968
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles with changed ChemSpider identifier
- Articles with changed KEGG identifier
- Articles with changed EBI identifier
- ECHA InfoCard ID from Wikidata
- Articles with changed InChI identifier
- Chemical pages without DrugBank identifier
- Multiple chemicals in Infobox drug
- Chemicals using indexlabels
- Chemical articles with multiple CAS registry numbers
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Alpha-1 blockers
- Carbamates
- Phenol ethers
- Piperazines
- Quinazolines
- All stub articles
- Antihypertensive agent stubs